Published in Cell Biol Toxicol on March 16, 2007
Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence. J Cell Mol Med (2009) 1.35
Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6). J Cell Mol Med (2007) 1.03
Thrombin and brain recovery after intracerebral hemorrhage. Stroke (2008) 0.91
Circulating progenitor cells and scleroderma. Curr Rheumatol Rep (2008) 0.89
Thrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells. J Cell Mol Med (2008) 0.81
The Role of Stem Cells in Wound Angiogenesis. Adv Wound Care (New Rochelle) (2014) 0.79
Comparative characteristics of endothelial-like cells derived from human adipose mesenchymal stem cells and umbilical cord blood-derived endothelial cells. Clin Exp Med (2013) 0.78
Sphingosine 1-phosphate elicits RhoA-dependent proliferation and MRTF-A mediated gene induction in CPCs. Cell Signal (2016) 0.75
Differential expression of Tie2 receptor and VEGFR2 by endothelial clones derived from isolated bovine mononuclear cells. PLoS One (2012) 0.75
Specific Recruitment of Circulating Angiogenic Cells Using Biomaterials as Filters. Acta Biomater (2017) 0.75
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost (2006) 2.17
Otitis media. Clinical observations, microbiology, and evaluation of therapy. Am J Dis Child (1968) 1.81
Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost (2005) 1.80
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost (2004) 1.79
Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost (1998) 1.71
Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia. Am Rev Respir Dis (1968) 1.58
Percutaneous transluminal angioplasty for emboligenic arterial lesions after radiotherapy of axillary arteries. J Vasc Surg (1995) 1.49
Thrombomodulin prolongs thrombin-induced extracellular signal-regulated kinase phosphorylation and nuclear retention in endothelial cells. Circ Res (2001) 1.49
Influence of CYP2C19 and CYP3A4 gene polymorphisms on clopidogrel responsiveness in healthy subjects. J Thromb Haemost (2007) 1.45
Antiphospholipid antibodies and atherosclerosis. Am J Med (1992) 1.41
[Rapid selection that rectifies a diagnosis of arteritis!]. Presse Med (2000) 1.39
Unexplained thrombosis and factor V Leiden mutation. Lancet (1994) 1.28
Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol (1997) 1.21
Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1997) 1.15
Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med (2001) 1.07
Protein C and protein S deficiencies. Semin Hematol (1997) 1.04
Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med (2000) 1.01
Met 358 to Arg mutation of alpha 1-antitrypsin associated with protein C deficiency in a patient with mild bleeding tendency. J Clin Invest (1992) 1.00
The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost (2004) 1.00
Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol (1999) 1.00
Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. Arterioscler Thromb Vasc Biol (2000) 0.95
Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur Respir J (2010) 0.95
Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group. Thromb Haemost (1994) 0.95
Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. Biomaterials (2007) 0.93
Elevated plasma fibrin D-dimer as a risk factor for vascular dementia: the Three-City cohort study. J Thromb Haemost (2009) 0.93
Resting metabolic rate and cost of locomotion in long-term fasting emperor penguins. J Appl Physiol Respir Environ Exerc Physiol (1980) 0.93
Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1993) 0.92
Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models. Immunol Rev (1999) 0.92
Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects. J Thromb Haemost (2009) 0.92
Activation-induced exposure of the thrombin anion-binding exosite. Interactions of recombinant mutant prothrombins with thrombomodulin and a thrombin exosite-specific antibody. J Biol Chem (1994) 0.92
Protein S deficiency: a database of mutations--summary of the first update. Thromb Haemost (2000) 0.92
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic disease. Thromb Haemost (2000) 0.92
Follow-up electron beam CT for the management of early phase Takayasu arteritis. J Comput Assist Tomogr (2001) 0.92
Protein S deficiency. Thromb Haemost (1997) 0.91
A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism. J Thromb Haemost (2010) 0.91
The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells. J Thromb Haemost (2006) 0.91
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 0.91
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases]. Sem Hop (1973) 0.90
Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference? Acta Anaesthesiol Scand (2010) 0.90
Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days. Thromb Haemost (2000) 0.90
Platelet microparticle levels: a biomarker of thromboangiitis obliterans (Buerger's disease) exacerbation. J Cell Mol Med (2009) 0.89
[Endovascular repair of a tuberculous aortic false aneurysm]. Rev Med Interne (2006) 0.89
Angiogenic potential of BM MSCs derived from patients with critical leg ischemia. Bone Marrow Transplant (2011) 0.89
Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost (1999) 0.87
Role of the P2Y12 gene polymorphism in platelet responsiveness to clopidogrel in healthy subjects. J Thromb Haemost (2006) 0.87
Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance. J Lab Clin Med (1995) 0.86
Changes in acid-base status of marathon runners during an incremental field test. Relationship to mean competitive marathon velocity. Eur J Appl Physiol Occup Physiol (1993) 0.86
Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis. Thromb Haemost (1987) 0.86
Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism. Br J Haematol (1997) 0.86
Molecular basis for protein S hereditary deficiency: genetic defects observed in 118 patients with type I and type IIa deficiencies. The French Network on Molecular Abnormalities Responsible for Protein C and Protein S Deficiencies. J Lab Clin Med (1996) 0.86
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study. J Thromb Haemost (2006) 0.86
Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy. Clin Pharmacol Ther (2008) 0.86
Myocardial infarction, Arg 506 to Gln factor V mutation, and activated protein C resistance. Lancet (1995) 0.86
Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase. Thromb Res (1984) 0.85
Ruling out acute deep vein thrombosis by ELISA plasma D-dimer assay versus ultrasound in inpatients more than 70 years old. Angiology (1999) 0.85
Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight? Thromb Haemost (1988) 0.85
An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro. Int Immunol (1996) 0.84
A novel gene overexpressed in the prostate of castrated rats: hormonal regulation, relationship to apoptosis and to acquired prostatic cell androgen independence. Endocrinology (1999) 0.84
Delivery management in a woman with thrombocytopenia of the May-Hegglin anomaly type. Eur J Obstet Gynecol Reprod Biol (2001) 0.83
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism. Arterioscler Thromb Vasc Biol (2000) 0.83
Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost (1997) 0.83
The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322. Transplantation (2000) 0.83
Absence of transplacental passage of fragmin (Kabi) during the second and the third trimesters of pregnancy. Thromb Haemost (1992) 0.83
Thirty-three novel mutations in the protein C gene. French INSERM network on molecular abnormalities responsible for protein C and protein S. Thromb Haemost (2000) 0.83
Selection and behavior of CD4+ CD25+ T cells in vivo: lessons from T cell receptor transgenic models. Curr Top Microbiol Immunol (2005) 0.83
Mutations in promoter region of thrombomodulin and venous thromboembolic disease. Arterioscler Thromb Vasc Biol (1999) 0.82
The profibrotic cytokine transforming growth factor-β1 increases endothelial progenitor cell angiogenic properties. J Thromb Haemost (2012) 0.82
A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost (2000) 0.82
PAR-1 genotype influences platelet aggregation and procoagulant responses in patients with coronary artery disease prior to and during clopidogrel therapy. Platelets (2005) 0.82
Successful treatment of ergotism with Iloprost--a case report. Angiology (1998) 0.82
Importance of the FcgammaRIIa-Arg/His-131 polymorphism in heparin-induced thrombocytopenia diagnosis. Thromb Haemost (1998) 0.82
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndrome. Br J Haematol (1997) 0.82
Thrombomodulin promoter mutations, venous thrombosis, and varicose veins. Arterioscler Thromb Vasc Biol (2001) 0.82
[Microvascular involvement in pseudoxanthoma elasticum. Capillaroscopic findings]. Presse Med (2004) 0.82
Clinical features in 36 patients homozygous for the ARG 506-->GLN factor V mutation. Thromb Haemost (1997) 0.81
[Cardiopulmonary function before and after cyclophosphamide treatment in severe systemic sclerosis: comparison of monthly intravenous bolus and autologous haematopoietic stem cell transplantation]. Rev Med Interne (2005) 0.81
P2Y1 gene polymorphism and ADP-induced platelet response. J Thromb Haemost (2005) 0.81
Arterial and venous thrombosis is associated with different angiogenic cytokine patterns in patients with antiphospholipid syndrome. Lupus (2010) 0.81
Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost (2004) 0.81
Topology of the stable serpin-protease complexes revealed by an autoantibody that fails to react with the monomeric conformers of antithrombin. J Biol Chem (1999) 0.81
Evaluation of a new disinfection procedure for ultrasound probes using ultraviolet light. J Hosp Infect (2006) 0.81